LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk

Richard Ofori-Asenso, Sophia Zoungas, Andrew Tonkin, Danny Liew

Research output: Contribution to journalComment / DebateOtherpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)235-238
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume104
Issue number2
DOIs
Publication statusPublished - 1 Aug 2018

Cite this

@article{0ff8b395e5524853b4dd4e04eb77b959,
title = "LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk",
author = "Richard Ofori-Asenso and Sophia Zoungas and Andrew Tonkin and Danny Liew",
year = "2018",
month = "8",
day = "1",
doi = "10.1002/cpt.1125",
language = "English",
volume = "104",
pages = "235--238",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "American Society for Clinical Pharmacology and Therapeutics",
number = "2",

}

LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk. / Ofori-Asenso, Richard; Zoungas, Sophia; Tonkin, Andrew; Liew, Danny.

In: Clinical Pharmacology and Therapeutics, Vol. 104, No. 2, 01.08.2018, p. 235-238.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk

AU - Ofori-Asenso, Richard

AU - Zoungas, Sophia

AU - Tonkin, Andrew

AU - Liew, Danny

PY - 2018/8/1

Y1 - 2018/8/1

UR - http://www.scopus.com/inward/record.url?scp=85050691024&partnerID=8YFLogxK

U2 - 10.1002/cpt.1125

DO - 10.1002/cpt.1125

M3 - Comment / Debate

VL - 104

SP - 235

EP - 238

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -